Single Injection Infromedial Peribulbar Injection in Lacrimal Duct
NCT ID: NCT04859049
Last Updated: 2022-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2021-09-10
2022-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Topical Anesthesia Alone Versus Combined With Intracameral LIdocaine 1%
NCT02215057
Corneal Endothelial Cell Loss After Phacoemulsification Compared With Extracapsular Cataract Extraction
NCT03262285
Study of Two-step Anesthesia in Intravitreal Injection
NCT03871062
Effect of Hyaluronidase on Intraocular Pressure
NCT03266406
Combined Intracameral Lidocaine for Manual Small Incision Cataract Surgery Under Topical Anesthesia
NCT01023334
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We gave the patient 5 ml of propofol to decrease the discomfort felt by the patient during injection of local anesthesia. Benox eye drops is applied to the operative eye in both groups.
Patients were allocated into 2 groups; each group is 25 patients Group 1: We used a 25G/ 1" length needle to inject 3ml of lidocaine: bupivacaine (1:1) with 30 IU hyaluronic acid, 0.5ml below the inferior punctum in the lower lid medial margin.
Group 2: We used a 25G/ 1" length needle to inject 3ml of lidocaine: bupivacaine (1:1) with 30 IU hyaluronic acid classical medial canthal injection
During surgery, we will assess the pain degree during probing using Verbal Rating Scale (0 to 10 scale where 0 is no pain an 10 is unbearable pain), to assess the efficiency of this single low volume injection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Infra- medial injection of local anesthesia mixture
infromedial single injection
Group 1: We used a 25G/ 1" length needle to inject 3ml of lidocaine: bupivacaine (1:1) with 30 IU hyaluronic acid, 0.5ml below the inferior punctum in the lower lid medial margin.
Group 2
medial canthus injection of the local anesthesia mixture
medial canthus injection
: We used a 25G/ 1" length needle to inject 3ml of lidocaine: bupivacaine (1:1) with 30 IU hyaluronic acid classical medial canthal injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
infromedial single injection
Group 1: We used a 25G/ 1" length needle to inject 3ml of lidocaine: bupivacaine (1:1) with 30 IU hyaluronic acid, 0.5ml below the inferior punctum in the lower lid medial margin.
medial canthus injection
: We used a 25G/ 1" length needle to inject 3ml of lidocaine: bupivacaine (1:1) with 30 IU hyaluronic acid classical medial canthal injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients' physical status by the American Association of Anesthesiology (ASA): ASA I, II, III.
* Age between 18-70, both sexes.
* Axial lengths ranging between 22-28mm.
Exclusion Criteria
* Patient age less than 18 or more than 70 years.
* Coagulation disorders (e.g. patients on warfarin (INR\<1.5)
* Communication difficulties preventing reliable assessment.
* High myopia (axial length more than 28mm) and medial staphylomas.
16 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Research Institute of Ophthalmology, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abeer Samir Salem
Researcher of anesthesia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
abeer salem, MD
Role: PRINCIPAL_INVESTIGATOR
research institute of ophthalmology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Institute of Ophthamology
Giza, , Egypt
Research Institute of Ophthalmology
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Abeer Samir Salem, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
anesth RIO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.